Signaling Pathway
Lokivetmab is a recombinant monoclonal antibody specifically targeting canine interleukin-31 (IL-31). This antibody is utilized primarily in the study of atopic dermatitis in dogs, providing a valuable tool for understanding the pathophysiology of this condition and the role of IL-31 in canine allergic responses.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Lokivetmab is a recombinant monoclonal antibody specifically targeting canine interleukin-31 (IL-31). This antibody is utilized primarily in the study of atopic dermatitis in dogs, providing a valuable tool for understanding the pathophysiology of this condition and the role of IL-31 in canine allergic responses. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
